The 12 closest competitors and alternatives to REGENEREX PHARMA, INC. among pharmaceuticals companies — ranked by similarity to what REGENEREX PHARMA, INC. actually does, not by market-cap band.
Subscribe to see REGENEREX PHARMA, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Regenerex Pharma, Inc. provides advanced wound care solutions and products, including specialized sterile wound creams like Xcellderma and Accelerex, designed to treat chronic and acute wounds such as diabetic foot ulcers, pressure ulcers, and burns. The company serves healthcare systems, managed care organizations, and federal agencies by offering turnkey wound closure programs and patented technology aimed at improving healing outcomes and managing treatment costs.
REGENEREX PHARMA, INC. is a pharmaceuticals company headquartered in United States. Xcout tracks 3 named people at REGENEREX PHARMA, INC., including Gregory P. Pilant (Chairman of the Board).
Ranked by semantic similarity — how close each company is to REGENEREX PHARMA, INC. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Nexsis Biosciences LLC distributes advanced tissue-repair products and biomaterials derived from porcine small intestinal submucosa (SIS) for surgical and wound management applications. The company serves healthcare providers and patients by offering extracellular matrix (ECM) devices that support site-specific tissue remodeling and healing without leaving permanent material behind.
Medical - Instruments & Supplies
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
Medical Technology
iMed Technology, Inc. is a US-based medical device manufacturer and business entity headquartered in Texas, specializing in single-use wound care and clinical products.
Medical Technology
Mölnlycke Health Care is a medical technology company that provides innovative wound care and surgical solutions for patients and healthcare professionals. The company serves hospitals, clinicians, and patients by offering products such as foam dressings, antiseptic products, and surgical environment supplies designed to improve care efficiency and clinical outcomes.
Healthcare
Medical Grade Innovations provides tailored solutions and products to healthcare facilities and communities to help minimize the spread of contagion and manage employees and patients. Their offerings include the WellFocused System for public health management and specialized medical-grade garments such as antimicrobial, moisture-wicking scrubs.
Pharmaceutical Manufacturing
Gerry Care, Inc. manufactures and distributes over-the-counter medications, vitamins, supplements, creams, and medical devices. The company provides private label manufacturing, wholesale supply, and distribution services to retailers, long-term care providers, government programs, and health systems across the United States.
Similar pharmaceuticals company
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.
Similar pharmaceuticals company
Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.
Healthcare & Pharmaceuticals
ActiMaris offers natural medical devices and solutions based on active singlet oxygen and sea salt to accelerate the healing of wounds, skin inflammation, and mucosal issues.
Similar pharmaceuticals company
Sonoma Pharmaceuticals, Inc. specializes in the creation and distribution of stabilized hypochlorous acid (HOCl) products. These offerings address a diverse range of medical and health needs, including wound management, veterinary care, ocular hygiene, oral health, and various dermatological conditions. The company's market reach extends across the United States, Latin America, Europe, and other international territories. Its comprehensive product line features: Epicyn: an antimicrobial cleanser for facial use. Levicyn: a prescription HOCl-based treatment formulated to ease the burning, itching, and pain associated with numerous dermatological issues. Celacyn gel: a topical HOCl-based prescription product engineered to facilitate efficient healing and management of both new and old scars. SebuDerm: designed to soothe the burning, itching, redness, scaling, and discomfort linked to seborrhea and seborrheic dermatitis. Acuicyn: an HOCl-based solution for alleviating ocular itch and inflammation, while also maintaining cleanliness around the eyes. Microcyn: a topical HOCl product family aimed at accelerating wound healing by combating a wide spectrum of pathogens, including antibiotic-resistant strains that can impede natural recovery. MicrocynAH: an HOCl-based solution specifically for animals, providing relief for common conditions like hot spots, scratches, skin rashes, post-surgical sites, and irritated skin to support healing. Microdacyn60: an oral care solution for treating infections of the mouth and throat. MucoClyns: suitable for emergency use and safe for application on mucous membranes, cuts, abrasions, burns, and other body surfaces. Endocyn: a series of solutions for root canal irrigation. Pediacyn: a hydrogel designed for atopic dermatitis. Ocucyn: a cleanser for eyelids and eyelashes. Gramaderm: for the topical treatment of mild to moderate acne. Nanocyn: a hospital-grade disinfectant. Sinudox: for nasal irrigation purposes. Originally incorporated in 1999 as Oculus Innovative Sciences, Inc., the company officially rebranded to Sonoma Pharmaceuticals, Inc. in December 2016. Its headquarters are located in Woodstock, Georgia.
Similar pharmaceuticals company
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Similar pharmaceuticals company
Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets both within the United States and internationally. A key offering includes its Triferic line (Triferic Dialysate and Triferic AVNU), an innovative iron replacement therapy. This therapy is designed to replenish iron and maintain healthy hemoglobin levels in dialysis patients, notably without increasing existing iron stores. Beyond iron management, Rockwell Medical manufactures, sells, and distributes a comprehensive range of hemodialysis concentrates. These include various acid concentrates such as CitraPure (citric), Dri-Sate (dry), and RenalPure (liquid), alongside a dry acid concentrate mixer, and powder bicarbonate concentrates like RenalPure and SteriLyte. These crucial products are vital for sustaining life in dialysis patients by facilitating the removal of toxins and the replacement of essential nutrients in their bloodstream. The company further supplies ancillary items critical for hemodialysis procedures. This extensive catalog comprises blood tubing, fistula needles, dialyzers, pharmaceuticals, specialized component kits, dressings, cleaning agents, filtration salts, and other necessary provisions utilized by hemodialysis providers. Looking to the future, Rockwell Medical is actively developing additional therapeutic candidates. These include treatments for hospitalized individuals suffering from acute heart failure, as well as solutions for home infusion therapy, enabling patients to receive intravenous medications in a home setting. The company primarily serves medium and small-sized dialysis chains, as well as independent dialysis centers. Established in 1996, Rockwell Medical, Inc. maintains its corporate headquarters in Wixom, Michigan.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for REGENEREX PHARMA, INC.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →